Member Info for elrico

A new flash note out today by Goetz has been loaded onto the lemming google groups forum.

https://groups.google.com/forum/#!topic/lemminginvestors/dHF5SL16mII

Chris, I'm unaware Sean Keyes has done a 360 or than he has been man enough to cop to the list of errors I exposed. If he has, then he has respect. In any event - he ignored me and SOH.

https://lemminginvestors.blogspot.com/2019/10/ai-has-seen-exception-growth-but-is.html

Roehampton recruiting for OPTI probiotic study.
https://lemminginvestors.blogspot.com/2019/10/optibiotix-health-lp-ldl-strain.html

Roehampton recruiting for OPTI probiotic study.
htTps://lemminginvestors.blogspot.com/2019/10/optibiotix-health-lp-ldl-strain.html

It should be noted 4D pharma (DDDD) announced a development agreement with MSD to develop vaccines worth in the region of up $347.5m which impacted on its SP. I don’t believe they have GRAS, GMP or humans studies showing safety and efficacy for their strain(s) which gives a sense of the opportunity of LP-LDL if OptiBiotix's biotherapeutic development progresses well, as well as demonstrates just how far ahead OptiBiotix is. I would caveat that all these developments are high risk but of course, the returns are equally high. 4D has a market valuation of £84m and has no fallback if the pharma route fails, of they do all too often. Furthermore, the pharma route is exceptionally expensive and very time consuming, thus frequent cash calls are the norm.

https://lemminginvestors.blogspot.com/2019/10/optibiotix-health-lp-dld-gains-rare-fda.html

Thanks, Parob.

There is much more going on, but Stuart is focussed on delivering the catalyst first. I can almost taste the excitement. You know I don't get ahead...

I'm confused. I've posted the same picture twice - Both colour.

Hi Rebarm, I honestly thought I made myself clear that I am also a whinger and whinner both in my comments on this site and the blog. We all have a right to offer opinions, good or bad, as long as we remain truthful. I can certainly tell you I made my POV known to SOH, just as I always do.

Yes, we are in agreement the SP has not been a great experience this past 12-18 month unless you were astute enough to get in low and bailout high. I did the former and remain an LTH.

You asked: Final observation and question! You conclude your post with, 'I won't mention the sums because you're-'re not interested in these type of quotes.' Where did that come from??

You wrote on Friday in post 192
" Also not interested in your quotes about what Seed may or may not achieve as I am 100% confident in their go-to-market strategy."

My comment about Seed included an estimated revenue figure.

Good chat. Refreshing.

https://twitter.com/LEMMINGINVESTOR/status/1183061971421351936

https://lemminginvestors.blogspot.com/2019/10/optibiotix-health-product-developments.html

I'm sure Bioenergise will hit the sweet-spot at some point. It is in their interest to do so. The more sales are developed the more they earn.

Hi rebarm, I mentioned Seed because you did when discussing marketing. I was merely pointing of the north by south poles apart the public charm offence is between the two when getting the message about the product out.

I think we are all in agreement about the lack of quality of the advertorial. The only redeeming feature is the scientific aspect and background of the team.

If Bio does achieve the revenues SOH believes they can, I think there will be less moaning and whining. I won't mention the sums because you're-'re not interested in these type of quotes. ;)

https://lemminginvestors.blogspot.com/2019/10/integumen-continues-to-build-strong.html

I think you're a little unfair. These early advertorials a designed to test feedback, presumably ahead of a TV campaign and or ahead of peak interest post-Christmas. I discussed a couple of issues with the advertorial as well as bring his attention to other issues people raised via the lemming google groups forum. As it happens, SOH has the same issues.

Ref Seed. I see your point. However, Seed do not need Bioenergiser, they are very astute marketers themselves. The use SM influencers, all of which must sit detailed exams before being enrolled in their influence system. Seed alone is expected to yeild c£1m, possibly as early as 2020 if all goes to plan with their expansion into new territories.

Hi Risky, I was referring to SlimBiome. Not wide awake at the time. :-)

This is the second test advertorial from BioEnergiser on SlimBiome. You will note its very different from the first which was somewhat male orientated with Steve Thompson. The idea is to try different approaches to build up an idea for what works and refine.



SlimBiome Medical is very different from the other weight management products which are simply about reducing calories and suffering the hunger. It will take a bit of testing in press and media to get it right both in terms of what media, what audience, and the timings of adverts. The first adverts are very much test adverts and we will see more in the forthcoming weeks and months.

Feel free to share.

Best Wishes,

Stephen OHara

A new adversarial is due to go out in Saturday express. These are early test adverts as part of the Bioenergiser partnership. They will be tweaked and refined as will the timing, etc.

This is the second, which can be viewed via my twitter account.

https://twitter.com/LEMMINGINVESTOR/status/1182339803020480517?s=19

It's all tea leaves. Essentially, need to hold above 54p for recovery to continue into 60s.

I would imagine passing phase III and proceed to production.

There is a correction to my earlier post related to India and Pakistan. The Company has an option, conditional on certain development milestones and further payments, to obtain a worldwide license (excluding India and Pakistan) under the same conditions.